Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Notes Payables (2016 - 2024)

Emergent BioSolutions (EBS) posted Notes Payables of $800000.0 for Q3 2024, down 99.81% on a QoQ basis from $415.2 million in Q2 2024, and down 99.81% year-over-year from $413.6 million in Q4 2023.

Analysis

Emergent BioSolutions (EBS) Notes Payables (2016 - 2024) Analysis & Trends

Emergent BioSolutions has reported Notes Payables for 8 years, with the latest figure at $800000.0 in Q3 2024.

  • On a quarterly basis, Notes Payables fell 99.81% year-over-year to $800000.0 in Q3 2024; TTM through Sep 2024 was $800000.0, a 99.81% decrease from a year earlier, with the FY2023 full-year figure at $413.7 million, down 56.78% from the prior year.
  • Notes Payables was $800000.0 for Q3 2024 at Emergent BioSolutions, down from $415.2 million in the prior quarter.
  • The five-year high for Notes Payables was $957.3 million in Q4 2022, with the low at $800000.0 in Q3 2024.
  • Average Notes Payables over 5 years is $231.0 million, with a median of $31.6 million recorded in 2021.
  • The sharpest annual moves came in 2022 and 2024: Notes Payables jumped 2929.43% in 2022, then sank 99.81% in 2024.
  • Over 5 years, Notes Payables stood at $33.8 million in 2020, then declined by 6.51% to $31.6 million in 2021, then surged by 2929.43% to $957.3 million in 2022, then tumbled by 56.78% to $413.7 million in 2023, then plunged by 99.81% to $800000.0 in 2024.
  • The last three Notes Payables figures came in at $800000.0 (Q3 2024), $415.2 million (Q2 2024), and $459.2 million (Q1 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn
9 Revolution Medicines 41.30 Bn 41.30 Bn -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 800,000.00
Jun 30, 2024 415.20 Mn
Mar 31, 2024 459.20 Mn
Dec 31, 2023 413.70 Mn
Sep 30, 2023 413.60 Mn
Jun 30, 2023 455.20 Mn
Mar 31, 2023 950.70 Mn
Dec 31, 2022 957.30 Mn
Sep 30, 2022 21.20 Mn
Jun 30, 2022 31.60 Mn
Mar 31, 2022 31.60 Mn
Dec 31, 2021 31.60 Mn
Sep 30, 2021 31.60 Mn
Jun 30, 2021 28.80 Mn
Mar 31, 2021 26.00 Mn
Dec 31, 2020 33.80 Mn
Sep 30, 2020 30.90 Mn
Jun 30, 2020 29.10 Mn
Mar 31, 2020 26.30 Mn
Dec 31, 2019 12.90 Mn
API Access

Emergent BioSolutions Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=EBS&period=max&api_key=YOUR_API_KEY